XML 37 R27.htm IDEA: XBRL DOCUMENT v3.5.0.2
Significant Accounting Policies, Stock-Based Compensation Expense (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Jun. 30, 2016
Jun. 30, 2015
Stock-based Compensation Expense [Abstract]        
Stock-based compensation expense $ 19,260 $ 13,605 $ 39,364 $ 26,910
Stock Options [Member]        
Unrecognized Compensation Expense [Abstract]        
Unrecognized compensation expense related to non-vested stock options 75,000   $ 75,000  
Weighted average period for recognition     1 year 4 months 24 days  
Stock Options [Member] | Board of Directors [Member]        
Stock-based Compensation Expense [Abstract]        
Options granted (in shares)     0 0
RSUs [Member]        
Stock-based Compensation Expense [Abstract]        
Vesting period     4 years  
Unrecognized Compensation Expense [Abstract]        
Unrecognized compensation cost related to non-vested RSUs 20,800   $ 20,800  
Weighted average period for recognition     1 year 7 months 6 days  
RSUs [Member] | Employees [Member]        
Stock-based Compensation Expense [Abstract]        
Weighted-average grant date fair value (in dollars per share)     $ 43.79  
RSUs [Member] | Board of Directors [Member]        
Stock-based Compensation Expense [Abstract]        
Units granted (in shares)     0 0
Research, Development and Patent Expenses [Member]        
Stock-based Compensation Expense [Abstract]        
Stock-based compensation expense 14,492 10,465 $ 29,262 $ 20,951
General and Administrative [Member]        
Stock-based Compensation Expense [Abstract]        
Stock-based compensation expense 4,768 3,140 10,102 5,959
Akcea Therapeutics [Member]        
Stock-based Compensation Expense [Abstract]        
Stock-based compensation expense $ 3,100 $ 1,000 $ 6,300 $ 1,500